Acceleron Reports Second Quarter 2018 Operating and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. DAL
9. TMUS
10. VZ

Go back to Acceleron Reports Second Quarter 2018 Operating and Financial Results

Acceleron Pharma (XLRN) Tops Q2 EPS by 1c

August 2, 2018 4:15 PM EDT

Acceleron Pharma (NASDAQ: XLRN) reported Q2 EPS of ($0.63), $0.01 better than the analyst estimate of ($0.64). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $3.8 million.

MEDALIST and BELIEVE Phase 3 trials met all primary and key secondary endpoints

ACE-083 Part 2 of the Phase 2... More